GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 8,800.00
-350.00 (-3.83%)
At close: Nov 13, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 158.01 billion as of November 13, 2026. It is the 23,752nd most valuable company in the world and the 928th biggest in South Korea. Its market cap has decreased by 8.10% in one year.
Market Cap
158.01B
Enterprise Value
243.81B
Revenue
192.21B
Global Rank
Country Rank
#928 South Korea
PE Ratio
32.71
ChartMarket Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 158.01B, a decrease of -28.79%. That is a compound annual growth rate of -4.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 158.01B | -2.58% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 227.13B |
| Vivozon Pharmaceutical | 179.59B |
| DAE HWA Pharmaceutical | 174.09B |
| CellBion | 157.06B |
| HEM Pharma | 156.44B |
| NOVAREX | 150.35B |
| Kyung Dong Pharmaceutical | 144.74B |
| PHARMARESEARCH BIO | 117.06B |